Research Proposal Sample for Mphil

INSTITUTIONAL RESEARCH ENGAGEMENT AND PROPOSAL AGREEMENT

Document ID: IRE-MPHIL-2024-08A
Effective Date: [Effective Date]
Version: 1.0.0
Governing Jurisdiction: [State/Country Governing Jurisdiction]

---

1. STATUTORY & LEGAL COMPLIANCE NOTICE

CLINICAL & INSTITUTIONAL DISCLAIMER:
This document is a legally binding Research Engagement and Proposal Agreement drafted by senior corporate legal counsel and contract operations architects. It establishes the legal, operational, and financial framework between an academic or research institution and a sponsoring entity, candidate, or client regarding an MPhil research proposal and execution project.

The user and participating entities must ensure that all bracketed fields are duly populated and that local institutional bylaws, academic regulations, human subjects institutional review board (IRB) requirements, and statutory export control laws are thoroughly reviewed by independent local counsel prior to formal execution. This instrument is designed for maximum enforceability across common law and hybrid civil jurisdictions, subject to local mandatory rules.

---

2. PARTIES & RECITALS

This Research Engagement and Proposal Agreement (the "Agreement") is entered into and made effective as of [Effective Date] (the "Effective Date"), by and between:

Research Institution / Provider:
[Company Full Legal Name], a [State of Incorporation/Organization] [Entity Type, e.g., non-profit corporation / university research foundation], having its principal place of business located at [Principal Address] (hereinafter referred to as the "Institution"), and

Sponsor / Client / Candidate:
[Client Full Legal Name], a [State of Incorporation/Organization] [Entity Type, e.g., corporation / individual researcher], having its principal place of business located at [Principal Address] (hereinafter referred to as the "Sponsor").

RECITALS

WHEREAS, the Institution possesses world-class academic, technical, and laboratory infrastructure capable of supporting advanced graduate-level research leading toward a Master of Philosophy (MPhil) degree;
WHEREAS, the Sponsor desires to commission, sponsor, and collaborate upon a structured academic research proposal and subsequent investigation titled "[Insert Exact Title of MPhil Research Proposal]" (the "Research Project");
WHEREAS, the parties intend to define their respective rights, financial commitments, intellectual property allocations, and confidentiality obligations concerning the execution and delivery of the Research Project under the terms and conditions set forth herein;

NOW, THEREFORE, in consideration of the mutual covenants, promises, and valuable consideration set forth herein, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

---

3. EXHAUSTIVE OPERATIVE CLAUSES & LEGAL TERMS

SECTION 1: SCOPE OF SERVICES & ENGAGEMENT

1.1 Research Proposal Formulation & Execution: The Institution agrees to furnish qualified academic personnel, facilities, and administrative oversight to develop, refine, and execute the MPhil research proposal annexed hereto as Exhibit A (the "Scope of Work").
1.2 Milestone Deliverables: The Institution shall deliver discrete milestones, progress reports, drafts, and the final MPhil dissertation proposal in strict accordance with the timeline specified in Exhibit B (the "Project Schedule").
1.3 Academic Independence: Notwithstanding any commercial sponsorship or funding provided by the Sponsor, the research methodology, data collection, analytical framework, and academic conclusions shall remain under the independent professional direction of the Institution’s appointed principal investigator and academic supervisors, ensuring academic integrity and adherence to institutional standards.

SECTION 2: COMPENSATION & PAYMENT TERMS

2.1 Total Contract Price: In consideration for the research services, proposal development, and administrative oversight rendered hereunder, the Sponsor shall pay to the Institution the total sum of [Amount in USD] USD (the "Contract Price"), payable in accordance with the milestone payment schedule set forth in Exhibit C.
2.2 Invoicing & Payment Terms: The Institution shall issue formal invoices to the Sponsor upon the completion and acceptance of each respective milestone. All invoices shall be due and payable in net thirty (30) calendar days from the date of receipt by the Sponsor via wire transfer or electronic clearinghouse to the bank account designated in writing by the Institution.
2.3 Late Payments & Interest: Any undisputed amounts not paid when due shall accrue interest at the lesser of one and one-half percent (1.5%) per month or the maximum rate permitted by applicable law, calculated from the date due until the date paid in full. The Institution reserves the right to suspend research operations, withhold milestone deliverables, or withhold final institutional endorsement of the MPhil proposal in the event of any material payment default persisting beyond ten (10) business days following written notice.
2.4 Taxes: The Contract Price is exclusive of all applicable federal, state, local, value-added, or sales taxes. The Sponsor shall be solely responsible for all such taxes, duties, and governmental levies arising out of this transaction, excluding taxes based solely on the net income of the Institution.

SECTION 3: TERM & TERMINATION

3.1 Term of Agreement: This Agreement shall commence on the Effective Date and shall continue in full force and effect until the completion of the Research Project and final delivery of the MPhil proposal, or until terminated earlier in accordance with the provisions of this Section 3 (the "Term").
3.2 Termination for Convenience: The Sponsor or the Institution may terminate this Agreement for convenience, in whole or in part, upon providing sixty (60) calendar days prior written notice to the non-terminating party. Upon termination for convenience, the Sponsor shall pay the Institution for all non-cancellable commitments, pro-rated services rendered, and direct costs incurred up to the effective date of termination.
3.3 Termination for Cause: Either party may terminate this Agreement immediately upon written notice if the other party materially breaches any of its representations, warranties, or material obligations hereunder and fails to cure such breach within thirty (30) calendar days after receipt of written notice detailing the specific breach.
3.4 Effect of Termination: Upon expiration or termination of this Agreement for any reason, the Institution shall promptly cease work on the terminated portion of the Research Project, return or destroy all Sponsor Confidential Information in accordance with Section 6, and deliver to the Sponsor all completed or partially completed interim reports and data deliverables paid for up to the date of termination.

SECTION 4: INTELLECTUAL PROPERTY OWNERSHIP & WORK MADE FOR HIRE

4.1 Background Intellectual Property: Each party shall retain exclusive right, title, and interest in and to all pre-existing patents, copyrights, trademarks, trade secrets, algorithms, and proprietary methodologies ("Background IP") owned or controlled by such party prior to the Effective Date or developed independently outside the scope of this Agreement.
4.2 Foreground Intellectual Property & Academic Rights: All inventions, discoveries, copyrightable works, research data, algorithms, and technical outputs conceived, reduced to practice, or authored primarily by the Institution's personnel, students, or researchers in the direct execution of the Research Project ("Foreground IP") shall be owned exclusively by the Institution, subject to academic publishing rights customary for higher education institutions.
4.3 Sponsor License Rights: The Institution hereby grants to the Sponsor a non-exclusive, worldwide, royalty-free, perpetual license to utilize the specific final MPhil research proposal and non-confidential operational deliverables for internal commercial or research purposes, excluding core academic data and institutional methodologies. Commercial exploitation of patentable inventions arising from the Research Project shall be subject to a separate, mutually negotiated commercial licensing agreement with reasonable commercial terms and royalties.

SECTION 5: MUTUAL CONFIDENTIALITY & NON-DISCLOSURE

5.1 Definition of Confidential Information: "Confidential Information" means any proprietary or non-public information disclosed by one party (the "Disclosing Party") to the other party (the "Receiving Party") under this Agreement, including technical data, trade secrets, research methodologies, financial data, and business plans, that is marked as confidential or that, by its nature or the circumstances of disclosure, ought reasonably to be treated as confidential.
5.2 Obligations of Confidentiality: The Receiving Party agrees to:

• (a) Hold the Disclosing Party’s Confidential Information in strict confidence;
• (b) Use the same degree of care to protect the confidentiality of such information as it uses to protect its own confidential information of like nature, but no less than a reasonable degree of care;
• (c) Restrict disclosure of such Confidential Information solely to its employees, academic supervisors, legal counsel, and contractors who have a strict need to know and who are bound by written confidentiality obligations at least as restrictive as those contained herein.
  5.3 Exclusions: Confidential Information shall not include information that:
• (a) Is or becomes generally known to the public through no breach of this Agreement by the Receiving Party;
• (b) Was already known to the Receiving Party prior to disclosure without an obligation of confidentiality;
• (c) Is independently developed by the Receiving Party without reference to or reliance upon the Disclosing Party’s Confidential Information; or
• (d) Is required to be disclosed by law, regulation, or court order, provided the Receiving Party gives prompt written notice to the Disclosing Party to enable it to seek a protective order.

SECTION 6: REPRESENTATIONS & WARRANTIES

6.1 Mutual Representations: Each party represents and warrants that:

• (a) It is duly organized, validly existing, and in good standing under the laws of its jurisdiction of incorporation or formation;
• (b) It has full corporate or institutional power and authority to enter into this Agreement and to perform its obligations hereunder;
• (c) The execution, delivery, and performance of this Agreement have been duly authorized by all necessary corporate or institutional actions.
  6.2 Institution Warranties: The Institution warrants that the research services shall be performed in a professional, workmanlike manner, consistent with generally accepted academic and scientific research standards.
  6.3 Disclaimer of Warranties: EXCEPT AS EXPRESSLY SET FORTH IN THIS SECTION 6, NEITHER PARTY MAKES ANY WARRANTIES, EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE, REGARDING THE RESEARCH PROJECT, DELIVERABLES, OR INTELLECTUAL PROPERTY, INCLUDING ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE, OR NON-INFRINGEMENT. ALL RESEARCH OUTPUTS ARE PROVIDED "AS IS."

SECTION 7: LIMITATION OF LIABILITY & INDEMNIFICATION

7.1 Limitation of Liability: TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, NEITHER PARTY SHALL BE LIABLE TO THE OTHER FOR ANY INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, PUNITIVE, OR EXEMPLARY DAMAGES, INCLUDING LOSS OF PROFITS, LOSS OF REVENUE, LOSS OF DATA, OR LOSS OF BUSINESS OPPORTUNITY, ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
7.2 Cap on Liability: THE AGGREGATE LIABILITY OF EITHER PARTY ARISING UNDER OR IN CONNECTION WITH THIS AGREEMENT, WHETHER IN CONTRACT, TORT (INCLUDING NEGLIGENCE), STRICT LIABILITY, OR OTHERWISE, SHALL IN NO EVENT EXCEED THE TOTAL CONTRACT PRICE ACTUALLY PAID BY THE SPONSOR TO THE INSTITUTION UNDER THIS AGREEMENT.
7.3 Indemnification: The Sponsor agrees to defend, indemnify, and hold harmless the Institution, its officers, trustees, faculty, employees, and students from and against any third-party claims, liabilities, losses, damages, or expenses (including reasonable attorneys' fees) arising out of or resulting from:

• (a) The Sponsor's commercial exploitation or use of the research proposal or deliverables;
• (b) Any breach of this Agreement by the Sponsor; or
• (c) The gross negligence or willful misconduct of the Sponsor, its agents, or contractors.

SECTION 8: DISPUTE RESOLUTION & ARBITRATION

8.1 Negotiation: In the event of any dispute, controversy, or claim arising out of or relating to this Agreement, the parties shall first attempt in good faith to resolve the matter through senior management negotiations within thirty (30) calendar days of written notice by either party.
8.2 Binding Arbitration: If the dispute is not resolved through negotiation, it shall be finally settled by binding arbitration administered by the [American Arbitration Association / International Centre for Dispute Resolution] in accordance with its Commercial Arbitration Rules. The place of arbitration shall be [City, State/Country]. The arbitration proceedings shall be conducted in the English language before a single neutral arbitrator. The award rendered by the arbitrator shall be final and binding, and judgment upon the award may be entered in any court having competent jurisdiction.
8.3 Injunctive Relief: Nothing in this Section 8 shall prevent either party from seeking preliminary injunctive relief or equitable remedies in a court of competent jurisdiction to protect its intellectual property rights or Confidential Information.

SECTION 9: GOVERNING LAW & JURISDICTION

9.1 Governing Law: This Agreement, and all claims or causes of action (whether in contract, tort, or statute) that may be based upon, arise out of, or relate to this Agreement, shall be governed by, enforced under, and construed in accordance with the internal laws of [State/Country Governing Jurisdiction], without regard to its conflict of laws principles.
9.2 Jurisdiction: Subject to Section 8, each party irrevocably and unconditionally submits to the exclusive jurisdiction of the state and federal courts located within [County, State/Country] for any legal action, suit, or proceeding arising out of or relating to this Agreement.

SECTION 10: MISCELLANEOUS

10.1 Severability: If any provision of this Agreement is held to be invalid, illegal, or unenforceable by a court or arbitrator of competent jurisdiction, such provision shall be modified to the minimum extent necessary to make it valid and enforceable, and the remaining provisions of this Agreement shall remain in full force and effect.
10.2 Counterparts: This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Execution and delivery of this Agreement by exchange of facsimile or portable document format (.pdf) signature blocks shall be valid and binding.
10.3 Entire Agreement: This Agreement, including all exhibits and schedules attached hereto, constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior and contemporaneous agreements, proposals, negotiations, representations, and understandings, whether written or oral.
10.4 Amendments & Waivers: No modification, amendment, or waiver of any provision of this Agreement shall be effective unless in writing and signed by an authorized representative of each party. No failure or delay by either party in exercising any right, power, or remedy under this Agreement shall operate as a waiver thereof.

---

4. EXECUTION & FORMAL SIGNATURE BLOCKS

IN WITNESS WHEREOF, the parties hereto have caused this Research Engagement and Proposal Agreement to be executed by their respective duly authorized officers as of the Effective Date first written above.

FOR [COMPANY FULL LEGAL NAME] (INSTITUTION):

Signature: _____________________________________
Printed Name: [Authorized Signatory Name]
Title: [Title / Role, e.g., Director of Research / Dean]
Company: [Company Full Legal Name]
Date: [Date]

FOR [CLIENT FULL LEGAL NAME] (SPONSOR / CLIENT):

Signature: _____________________________________
Printed Name: [Authorized Signatory Name]
Title: [Title / Role, e.g., Chief Executive Officer / Sponsor Representative]
Company: [Client Full Legal Name]
Date: [Date]

---

5. STEP-BY-STEP EXECUTION & FILING GUIDE

1. Document Preparation & Field Population:
   Open the electronic document (in Microsoft Word or Google Docs) and locate all bracketed fields (e.g., [Company Full Legal Name], [Effective Date], [Amount in USD]). Replace every bracketed placeholder with accurate, verified legal and financial data. Do not leave any unpopulated brackets.

2. Verification of Signatory Authority:
   Confirm that the individuals signing on behalf of both the Institution and the Sponsor possess formal corporate or institutional authority (verified via corporate resolutions, bylaws, or institutional mandates) to bind their respective legal entities to financial and legal obligations.

3. Exhibit Attachment:
   Ensure that Exhibit A (Scope of Work / MPhil Proposal Details), Exhibit B (Project Schedule & Milestones), and Exhibit C (Payment Terms) are fully drafted, attached, and cross-referenced prior to initiating the signing process.

4. Digital Signature Execution:
   Upload the finalized PDF agreement into an enterprise-grade digital signature platform (such as DocuSign or Adobe Sign). Route the document sequentially or simultaneously to the designated authorized signatories. Ensure audit trails and cryptographic certificates are retained.

5. Post-Execution Filing & Record Retention:
   Upon full execution, store the master executed copy in the Institution's secure legal and contract management repository (CLM) and provide a duplicate original to the Sponsor. Retain all agreement records, invoices, and milestone deliverables for a minimum of seven (7) years following the expiration or termination of the Term, or as required by institutional compliance policies.